Cancer trials support unit (ctsu) IDIQ

Active Awarded Last action

Contract number
75N91022D00013
Awardee
Awarding agency
Task orders
1 $5,226,632 obligated

Award facts

Opportunity
Combined order value
  • $5,390,639 Current, with exercised options
  • $6,129,860 Potential, with all options
Last date to order 85% complete
IDV ceiling 1% used
$548,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
Partial Small Business
Competition
Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), has awarded a $548 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to multiple small business contractors, including EDJ Associates, Inc., to provide operational and administrative support for NCI's cancer clinical trial networks through the Cancer Trials Support Unit (CTSU) program.

The initial task order issued under this IDIQ, valued at $6,129,860, is for a project kickoff meeting and awareness, education, and training services. The contract has a period of performance from August 1, 2022 through July 31, 2027. The overall CTSU IDIQ aims to provide broad-based, centralized support services across six task areas, including project kickoff, core support services, awareness and training, site study setup, protocol and scientific writing, and electronic patient-reported outcomes. Some task areas are partially set aside for small businesses. The incumbent contractors under the previous CTSU IDIQ were Westat, Inc., PPD, and Technical Resources Inc.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N91022D00013?

75N91022D00013 was awarded to EDJ Associates, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2022.

How much is contract 75N91022D00013 worth?

Orders under 75N91022D00013 have obligated $5,226,632. Their combined current value, with exercised options, is $5,390,639. Their combined potential value, with all options, is $6,129,860. 75N91022D00013's own ceiling is $548,000,000.

How many orders have been placed under contract 75N91022D00013?

1 order has been placed under 75N91022D00013, the latest on August 1, 2022.

Who can order from contract 75N91022D00013?

75N91022D00013 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N91022D00013 part of a contract vehicle?

Yes. 75N91022D00013 is part of Cancer Trials Support Unit.

Was contract 75N91022D00013 competed?

The extent of competition for 75N91022D00013 was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Partial Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV